In a health expenditure framework, the question of the relative cost-effectiveness ratio of new medical technologies is essential. The EVIDENCE-RM retrospective study, conducted by Implicity, provided concrete elements on the medical-economic impact of remote...
Comprehensive analysis of real-world data shows significant clinical and medico-economic advantages of Implicity’s universal, alert-based remote monitoring platform. Cambridge, Mass., April 24, 2025 – IMPLICITY®, a leader in remote patient monitoring and...
Technological innovation in healthcare continues to demonstrate its positive impact on patient care. Implicity, an agnostic remote cardiac monitoring platform, conducted a large-scale retrospective study, EVIDENCE-RM¹, to assess the benefits of its platform in...
The type of monitoring platform used when remotely monitoring patients with cardiac implantable electronic devices (CIEDs) can significantly affect patient care. Non-alert-based platforms regularly collect and transmit data from patients’ devices, which clinicians can...
September is not just about the changing seasons or the back-to-school rush; it's also a significant month for health awareness. Among the various health observances, AFib Awareness Month stands out, dedicated to raising awareness about atrial fibrillation (AFib)—a...
Remote Patient Management (RPM) is more than just a technological innovation; it’s a game-changer in how we deliver cardiovascular care. The American College of Cardiology has highlighted eight critical objectives* that illustrate the transformative potential of RPM:...
SignalHF*, an FDA-cleared AI algorithm, is becoming an essential ally for cardiac remote monitoring teams in a groundbreaking stride toward proactive healthcare management. With its capability to predict heart failure hospitalizations within 30 days, SignalHF stands...
Cutting-edge tool analyzes data from cardiac remote monitoring devices to assess whether a patient is at high risk of experiencing worsening heart failure, enabling medical teams to intervene and avoid hospitalization. Cambridge, Mass., May 17, 2024 – Implicity, a...
Cambridge, Mass., December 12, 2023 – Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners...
Recent recommendations for remote monitoring of implantable devices may require healthcare organizations to rethink how they staff their operations This past spring, electrophysiology experts issued new recommendations for remote monitoring of cardiovascular...
Cambridge, Mass., October 24, 2023 – Implicity, a leader in remote patient monitoring (RPM) and cardiac data management solutions, today announced the results of a clinical study published in the Cardiovascular Digital Health Journal. The findings show Implicity’s...
Healthcare is one of many sectors poised for AI transformation, but it poses unique challenges, opportunities, and considerations. For those of us who have been working closely with artificial intelligence (AI) for many years, it’s a little shocking to suddenly hear...
Cambridge, Mass., September 27, 2023 – Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced that Jon Hunt, PhD., has joined the company as its new Chief Commercial Officer (CCO) in North America. In this role, Hunt will...
Cambridge, Mass., September 18, 2023 – Implicity, a leader in remote patient monitoring (RPM) and cardiac data management solutions, announced today that founder and CEO Arnaud Rosier, MD, PhD, has been selected to participate in a panel discussion at the upcoming HRX...
A new scientific study, led by Dr. Niraj Varma and conducted by a team of leading experts, has cemented the importance of remote cardiac monitoring for Cardiac Implantable Electronic Devices (CIEDs). Published in Europace 2023, the paper "Remote monitoring of cardiac...
A new clinical trial on remote monitoring found that while all patients involved saw improved survival rates, the type of remote monitoring had a significant impact. Implicity, a developer of alert-based remote monitoring solutions, in collaboration with the Health...
Since the 2015 Heart Rhythm Society's expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices, remote monitoring for patients with (CIEDs) has been recognized as the gold standard.1 Connectivity became even...
Transparency and Compliance in Healthcare AI is Crucial In recent years, the advent of artificial intelligence (AI) and machine learning (ML) in healthcare has changed the landscape in how we diagnose, treat, and manage medical conditions. At Implicity, we've been at...
The Intersection of AI and Remote Monitoring in Reducing Alert Burden is a Critical Path Forward in Cardiac Care. In the realm of cardiac healthcare, the role of remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is pivotal. However, the vast...
Transform your device clinic with automated data collection and seamless integration. Designed to streamline the collection and transmission of in-clinic data, InLink is a smart tool that automatically collects patient device data - including PDF files and raw data...
Data-driven insights from cardiac implantable electronic devices (CIEDs) can revolutionize research, leading to transformative discoveries in the healthcare field. In the ever-evolving healthcare field, the ability to collect and analyze data is paramount for...
Telemedicine is here to stay. But that doesn’t mean that in-person healthcare is going anywhere – soon or ever. It’s becoming clear that a hybrid approach is the way forward for the healthcare sector, with many hospitals and clinics already relying on remote...
Since 2015, remote monitoring has been the standard practice for managing patients with cardiovascular implantable electronic devices, leading to decreased morbidity and mortality. The significant benefits of remote monitoring have been evident over the past eight...
Artificial intelligence (AI) is one of the most promising breakthrough technologies of the modern healthcare era, yet it also has the potential to be one of the most dangerous. AI algorithms trained on limited or poorly representative data sets can exhibit...
Cambridge, Mass., May 22, 2023 – Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced the findings of a study presented during a late-breaking clinical trial session at the Heart Rhythm Society’s (HRS) annual meeting. The...
In-clinic tool automatically and securely links manufacturer programmers with Implicity’s data management solution for faster, more efficient remote monitoring workflows Cambridge, Mass., April 18, 2023 – Implicity, a leader in remote patient monitoring and cardiac...
New feature tackles atrial fibrillation burden, reducing the alerts for patients being treated with anticoagulant medication and highlighting clinically significant events. Cambridge, Mass., April 12, 2023 – Implicity, a leader in remote patient monitoring and cardiac...
New app improves cardiac remote monitoring workflows by providing clinicians access to Implicity alerts and reports directly within Epic’s electronic medical records systems. Cambridge, Mass., March 2, 2023 – Implicity®, a leader in remote patient monitoring (RPM) and...
Improving population health by harnessing the power of digital data fuels the innovative spirit at Implicity. Our effort is supported by the - feedback from the health providers we serve.One way we receive feedback and assess user satisfaction is through a net...
The Association of German Cardiologists BNK Service GmbH lists the telemonitoring system “hedy” from HCSG and IMPLICITY to cardiologists in private practice. As a unique cloud-based and vendor-independent platform for heart failure telemonitoring, hedy enables...
Those who have dedicated their lives to cardiology are experiencing burnout at a record pace. This is especially true for physicians and medical teams remotely monitoring patients with CIEDs (Cardiac Implantable Electronic Devices). The growing number of patients...
Electrophysiologist Arnaud Rosier, CEO, and Co-Founder at Implicity, sits down with LABIOTECH to discuss AI's expanding role in Cardiology “In 2023, we will see the first large-scale use of AI algorithms in healthcare. Several factors, including the speed of...
The use of AI in electrophysiology is increasing; it’s being applied to personalize treatment to achieve better outcomes, to manage patients more effectively, and it’s relieving the burdensome workflow of a data-intensive clinical practice. Electrophysiology is among...
Healthcare providers are swamped with false alarms from remote patient monitoring systems. Here’s how AI can help solve the problem. Remote patient monitoring systems have made enormous inroads in healthcare in recent years, especially for chronically ill patient...
Burnout among doctors and nurses was already a major problem facing healthcare organizations, even before the COVID pandemic – maybe even more for healthcare professionals working in the extremely demanding field of cardiology. It’s not just a matter of long hours and...
Remote patient monitoring solutions are producing more patient data each year. The only way for healthcare providers to process it all – and support their patients – is with artificial intelligence-based tools. Once a technology enters our lives, it becomes impossible...
Company named a Top 8 Super Finalist in the global health tech competition identifying the most disruptive companies shaping the future of digital health. Cambridge, Mass., November 8, 2022 – Implicity®, a leader in remote patient monitoring and cardiac data...
Dr. Arnaud Rosier, the co-founder of the health tech company Implicity, provides a window into how artificial intelligence impacts his field. Hi, please tell us about your journey in AI technology and how you started with Implicity. I founded Implicity about six years...
Industry veterans Vanessa Joyce named VP of Sales for North America and Megan Grosz appointed Head of Global Marketing and Communications Cambridge, Mass., September 28th, 2022 – Implicity®, a leader in remote patient monitoring and cardiac data management...
The first implantation of a pacemaker in a human occurred in 1958. Since then, the technology behind permanent cardiac rhythm management has steadily evolved, enabling a variety of implants known collectively as cardiac implantable electronic devices (CIEDs). Today,...
Dr. Arnaud Rosier, the co-founder of Implicity®, discusses how artificial intelligence can impact healthcare. Last fall, Implicity received clearance from the Food and Drug Administration for a novel AI algorithm that analyzes ECG data from Implantable Loop Recorders...
The two companies offer a complete solution for German telemedicine centers, including equipping patients with the devices and a TMZ portal for heart failure remote monitoring with external sensors and implants. Munich and Paris, May 20th, 2022 -- HCSG and IMPLICITY,...
Series A funding round will accelerate international expansion and fuel AI-based medical algorithm development. Cambridge, Mass., April 27th, 2022 – IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, today announced it has raised...
Cardiac health issues typically require frequent monitoring, regular interventions, and quick decision-making when symptoms arise, which can place significant burdens on patients. Accessing the most appropriate care for the situation can be a major challenge for...
A key highlight will include a Rhythm Theater presentation focused on the constraints and challenges of remote cardiac monitoring (RCM), as well as the impact of AI in managing ILR dataflows and transforming RCM into an opportunity for clinical research. Cambridge,...
By drastically reducing false positives, artificial intelligence tools make remote monitoring a more practical option for cardiologists and electrophysiologists Remote patient monitoring (RPM) tools have been around – and performing at a high level – for years. In...
Clinical and academic researchers can apply for one of three spots for free access to cardiac remote monitoring and ILR ECG Analyzer to support CRM research Cambridge, Mass., March 10th, 2022 – Implicity, a leader in AI-powered remote patient monitoring and cardiac...
What is Atrial Fibrillation? Atrial fibrillation (AF) is the most frequent cardiac arrhythmia. AF is a significant burden to healthcare professionals and society, with an increased risk of stroke and embolism. Its incidence varies with age, from 1.7% for the youngest...
One year into the COVID-19 crisis, the United Kingdom is still under lockdown. The virus has paralyzed the nation and has changed healthcare delivery especially for people with life-threatening conditions. Remote monitoring has proved to be extremely effective to care...
Following the announcement of a policy to transform the health system by the president of the French Republic, A national digital health roadmap was created in April 2019 to reflect the collective commitment to implement digital healthcare in France. The Ministry of...
Big data analysis and artificial intelligence in healthcare are among the most significant advancements in medicine so far. The AI race is on and Europe is leading with the most top AI researchers according to the H-index measure of quality.
Despite numerous and robust proofs of clinical and medico-economic benefits[1], Cardiac electronic implantable devices (CIEDs) remote monitoring was not broadly adopted in France until a few years ago due to the lack of the service reimbursement for healthcare...